Furthermore, the BCLC scores as well as ALT/AST levels and viral load in NAs treated CHB-related HCC patients was significantly better than that NAs naïve, suggesting that NAs significantly reduced the severity of CHB-related HCC. This evidence concerns the gene GPT and hepatocellular carcinoma.